GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panacos Pharmaceuticals Inc (GREY:PANC) » Definitions » Cyclically Adjusted Revenue per Share

Panacos Pharmaceuticals (Panacos Pharmaceuticals) Cyclically Adjusted Revenue per Share : $0.00 (As of Sep. 2008)


View and export this data going back to 1998. Start your Free Trial

What is Panacos Pharmaceuticals Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Panacos Pharmaceuticals's adjusted revenue per share for the three months ended in Sep. 2008 was $0.000. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.00 for the trailing ten years ended in Sep. 2008.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-06-20), Panacos Pharmaceuticals's current stock price is $0.0001. Panacos Pharmaceuticals's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2008 was $0.00. Panacos Pharmaceuticals's Cyclically Adjusted PS Ratio of today is .


Panacos Pharmaceuticals Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Panacos Pharmaceuticals's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panacos Pharmaceuticals Cyclically Adjusted Revenue per Share Chart

Panacos Pharmaceuticals Annual Data
Trend Dec98 Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Panacos Pharmaceuticals Quarterly Data
Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Panacos Pharmaceuticals's Cyclically Adjusted Revenue per Share

For the Biotechnology subindustry, Panacos Pharmaceuticals's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Panacos Pharmaceuticals's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Panacos Pharmaceuticals's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Panacos Pharmaceuticals's Cyclically Adjusted PS Ratio falls into.



Panacos Pharmaceuticals Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Panacos Pharmaceuticals's adjusted Revenue per Share data for the three months ended in Sep. 2008 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Sep. 2008 (Change)*Current CPI (Sep. 2008)
=0/92.3069*92.3069
=0.000

Current CPI (Sep. 2008) = 92.3069.

Panacos Pharmaceuticals Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
199812 8.265 69.151 11.033
199903 9.285 69.615 12.312
199906 7.636 70.122 10.052
199909 4.781 70.839 6.230
199912 7.135 71.008 9.275
200003 6.001 72.231 7.669
200006 4.714 72.737 5.982
200009 4.737 73.286 5.966
200012 5.038 73.413 6.335
200103 5.254 74.341 6.524
200106 4.031 75.100 4.955
200109 2.285 75.227 2.804
200112 0.622 74.552 0.770
200203 0.862 75.438 1.055
200206 0.825 75.902 1.003
200209 0.080 76.366 0.097
200212 0.090 76.324 0.109
200303 0.046 77.716 0.055
200306 0.037 77.505 0.044
200309 0.026 78.138 0.031
200312 0.144 77.758 0.171
200403 0.511 79.066 0.597
200406 0.057 80.037 0.066
200409 0.071 80.121 0.082
200412 0.092 80.290 0.106
200503 0.045 81.555 0.051
200506 0.007 82.062 0.008
200509 0.004 83.876 0.004
200512 0.003 83.032 0.003
200603 0.004 84.298 0.004
200606 0.001 85.606 0.001
200609 0.001 85.606 0.001
200612 0.000 85.142 0.000
200703 0.000 86.640 0.000
200706 0.002 87.906 0.002
200709 0.001 87.964 0.001
200712 0.000 88.616 0.000
200803 0.001 90.090 0.001
200806 0.000 92.320 0.000
200809 0.000 92.307 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Panacos Pharmaceuticals  (GREY:PANC) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Panacos Pharmaceuticals Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Panacos Pharmaceuticals's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Panacos Pharmaceuticals (Panacos Pharmaceuticals) Business Description

Industry
Traded in Other Exchanges
N/A
Address
134 Coolidge Avenue, Watertown, MA, USA, 02472
Panacos Pharmaceuticals Inc is a biotechnology company that seeks to develop next generation anti-infective products through the discovery and development of small-molecule oral drugs designed to treat HIV and other human viral diseases.

Panacos Pharmaceuticals (Panacos Pharmaceuticals) Headlines

No Headlines